Searched for
AJANTA PHARMACEUTICALS
PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facilityAjanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...
- Buy Ajanta Pharma, target price Rs 2030: ICICI SecuritiesAjanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the yea...
- Buy Ajanta Pharma, target price Rs 1495: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16369.91 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 1495: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16207.83 Crore) operating in Pharmaceuti...
- Hold Ajanta Pharma, target price Rs 1305: ICICI DirectAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 15564.46 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 2080: Motilal OswalAjanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13758.77 Crore) operating in Pharmaceuti...
- Buy Ajanta Pharma, target price Rs 2500: Motilal Oswal SecuritiesAjanta Pharma key Products/Revenue Segments include Pharmaceutical Products, Export Incentives and Other Operating Revenue for the year end...
- Sell Ajanta Pharma, target Rs 970: Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 970.0 and a stop loss at Rs 995 from the entry point.
- Sell Ajanta Pharma, target Rs 1,250: Jay ThakkarSell Ajanta Pharma Ltd. at a price target of Rs 1250.0 and a stop loss at Rs 1396 from entry point.
- Buy Ajanta Pharma, target Rs 1,520: Kunal BothraBuy Ajanta Pharma Ltd. at a price target of Rs 1520.0 and a stop loss at Rs 1410 from entry point.
- Buy Ajanta Pharma, target Rs 1,560: Kunal BothraBuy Ajanta Pharma Ltd. at a price target of Rs 1,560.0 and a stop loss at Rs 1,465 from entry point.
- Buy Ajanta Pharma, target Rs 1,350: Kunal BothraBuy Ajanta Pharma at a price target of Rs 1,350 and a stop loss at Rs 1,220 from entry point.
- Buy Ajanta Pharma, target Rs 1,300: Kunal BothraBuy Ajanta Pharma at a price target of Rs 1,300 and a stop loss at Rs 1,210 from entry point.
- Ajanta Pharma jumps on talks with Dabur India to sell brandAjanta Pharma rose more than 6 pc after Dabur India was in talks to buy '30-Plus' multi-vitamin supplement brand from Ajanta Pharma.
Load More
